SFG Trading Services ltd

11/02/2015

http://www.businessinsider.com/a-prop-trader-explains-his-work-his-salary-and-why-everyone-is-wrong-about-his-kind-2012-4

10/01/2015

Behind the strange small-cap underperformance

Small-cap stocks have underperformed large caps lately. The Russell 2000 is down 5.2 percent in the past week and 6.8 percent in the past month, versus S&P 500 declines of 3 percent and 5.3 percent, respectively.

The small-cap lag comes despite a market environment in which smaller companies might be expected to do better. After all, one of the biggest current worries is global growth, and Russell 2000 businesses tend to be more domestic-focused than those in the S&P 500. For more information please visit us http://www.cnbc.com/2015/09/29/behind-the-strange-small-cap-underperformance.html

If global growth is the big concern, why are the more domestically focused small-cap stocks lagging?

10/01/2015

Facebook is going to $100: Trader

The information technology sector dragged on the S&P 500 on Tuesday as stocks struggled to hold onto gains. Within the group, Facebook was one of the worst performers, tumbling about 3 percent.

However, one options trader thinks the social media company could rally 15 percent in just one month. For more information please visit us http://www.cnbc.com/2015/09/29/facebook-is-going-to-100-trader.html

Facebook shares have fallen more than 6 percent in one week, but one trader is betting that it will see a substantial rally in one month's time.

10/01/2015

Stocks are going higher—here's how to profit: Trader

Traders Todd Gordon and Andrew Keene are trading the market's next move—and taking your live calls and tweets! For more information please visit us http://www.cnbc.com/2015/09/30/stocks-are-going-higher-heres-how-to-profit-trader.html

Traders Todd Gordon and Andrew Keene live-trade the market's next move.

09/30/2015

Nike and Under Armour both score on Wall Street

It's like the end of "Trading Places" -- when someone asks if they should have the lobster or cracked crab for lunch. The classic response: Can't we have both?
Although Nike (NKE) and Under Armour (UA) are in a heated battle for sneaker market share and star endorsers, each athletic apparel maker is a big winner on Wall Street. For more information please visit us http://money.cnn.com/2015/09/28/investing/nike-under-armour-stocks/index.html

Nike or Under Armour? Can't we have both?

09/30/2015

Dow tumbles 313 points as biotech gets crushed

The Dow slid 313 points and the S&P 500 lost 2.6% on Monday. The Nasdaq experienced steeper losses, shedding 3%. It was the Nasdaq's worst one-day decline since August 24, the day the Dow took an unprecedented 1,000-point nosedive.
The biotech sector continues to get crushed. Long a favorite of investors, biotech stocks have stumbled amid concerns that political pressure will end steep drug price increases. For more information please visit us http://money.cnn.com/2015/09/28/investing/stocks-markets-dow-biotech/index.html

The stock market is very skittish and biotech stocks are feeling the most pain.

09/30/2015

Biotech stocks crushed under political pressure

Drug makers are coming under fire for price-gouging, sending biotech socks plummeting. For more information please visit us http://money.cnn.com/video/investing/2015/09/29/biotech-stocks-plunge.cnnmoney/index.html

Drug makers are coming under fire for price-gouging, sending biotech socks plummeting.

09/30/2015

The stock market bull may not be dead yet

The calendar may still read September, but weary investors are already starting to get their hopes up for a so-called Santa Claus rally in the fourth quarter.
The past three months have been brutal. The Dow, S&P 500 and Nasdaq have each plunged about 9% so far in the third quarter and are in the red for the year.
They are also all in a so-called correction -- down more than 10% from a recent peak. This will be the worst quarter for stocks in four years -- the last time the market had a correction.
There is a lot to worry about. For more information please visit us http://money.cnn.com/2015/09/29/investing/stocks-third-quarter-fourth-quarter-rally/index.html

The third quarter was ugly for the stock market. But history shows that a rebound is likely for the fourth quarter. Experts explain why they are still bullish on stocks despite many risks.

09/30/2015

Biotech bull market is dead

Fueled by incredible innovation and rapid revenue growth, the S&P 500 biotechnology index skyrocketed more than 400% between July 2010 and July 2015. Biotech superstars like Gilead Sciences (GILD) and Regeneron (REGN) posted even more monstrous rallies. For more information please visit us http://money.cnn.com/2015/09/29/investing/biotech-bull-market-bear-bubble/index.html

The biggest bull market ever in biotech stocks has been killed by the threats from politicians to curb price hikes.

09/30/2015

Investors Pull About $40 Billion From Emerging Markets in Current Quarter

Foreign capital is gushing out of emerging markets.

Global investors are estimated to have yanked $40 billion from emerging-market stocks and bonds during the current quarter, the most for a quarter since the depths of the 2008 global financial crisis, according to the latest data from the Institute of International Finance. Read it http://www.wsj.com/articles/investors-pull-about-40-billion-from-emerging-markets-in-current-quarter-1443553952

Global investors are estimated to have pulled $40 billion from emerging-market stocks and bonds during the current quarter, the most for a quarter since 2008.

09/30/2015

Stocks Show Signs of Steadying

U.S. stocks edged higher Tuesday, but pared their sharpest gains as a rally in biotechnology shares fizzled.

The Dow Jones Industrial Average rose 47.24, or 0.3%, to 16049.13, while the S&P 500 added 2.32, or 0.1%, to 1884.09.

The Nasdaq Composite Index shed 26.65, or 0.6%, to 4517.32.

Stocks bounced from the opening bell, with the Dow notching a 117-point rise that reversed course as the day went on. A recovery in beaten-down biotech stocks lost steam, sending the Nasdaq Biotechnology Index down 0.6%. The index is down 18% in the last month. For more information please visit us http://www.wsj.com/articles/global-stocks-selloff-continues-1443515026

A sharp selloff in global stocks continued as the recent slump in mining shares added to investors’ worries over the impact of a slowdown in China.

09/30/2015

Glencore Investors Zero In on Trading Unit

LONDON—Glencore PLC’s large trading division has moved into investors’ cross hairs amid concerns that the $18 billion in short-term loans it uses to buy, sell and ship goods is riskier than the company says.For more information please visit us http://www.wsj.com/articles/glencore-investors-zero-in-on-trading-unit-1443569006

Glencore’s trading division has come under the wary eye of investors over its debt load, while executives mounted a defense of the company’s business model.